Blueprint Genetics
Blueprint Genetics to Analyze Biobank Samples for Rare Diseases in New Finnish Study
Researchers plan to identify and sequence the exomes of 3,000 individuals from the biobank who are likely to have one of a number of rare diseases.
Blueprint Genetics, NICER Consortium Developing Genetic Test for Immunologic, Hematologic Disorders
Blueprint Genetics, recently acquired by Quest Diagnostics in January, will base the 600-gene panel on its whole-exome sequencing capability.
In Brief This Week: LineaRx, OncoCyte, Vela Diagnostics, CosmosID, More
News items for the week of Feb. 3, 2020.
Quest Diagnostics Aims to Leverage Blueprint Acquisition to Advance Genetic Testing Portfolio
Premium
The company expects that Blueprint's informatics capabilities in particular will improve variant interpretation and reporting across all its genetic test offerings.
Quest Diagnostics Acquires Blueprint Genetics
Blueprint provides 3,900 targeted single-gene and more than 200 panel tests covering 14 medical specialties, leveraging NGS and bioinformatics methods.
Oct 3, 2019
Mar 13, 2018